Evidence map›Paper›PMID 42234006›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Quantitative

Tina Nazerani-Zemann, Susanne Stanzel, Friedrich Weitzer, Thomas Kuenzer, Verena Maria Stangl, Jan Bucerius

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tina Nazerani-ZemannDepartment of Radiology, Division of Nuclear Medicine, Medical University of Graz, Auenbruggerplatz 9A, Graz, 8036, Austria. tina.nazerani-zemann@medunigraz.at.ORCID 0000-0002-3539-8771
Susanne StanzelDepartment of Radiology, Division of Nuclear Medicine, Medical University of Graz, Auenbruggerplatz 9A, Graz, 8036, Austria.
Friedrich WeitzerDepartment of Radiology, Division of Nuclear Medicine, Medical University of Graz, Auenbruggerplatz 9A, Graz, 8036, Austria.
Thomas KuenzerInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Auenbruggerplatz 2, Graz, 8036, Austria.
Verena Maria StanglDiagnostic and Research Institute of Pathology, Diagnostic and Research Center of Molecular BioMedicine, Medical University of Graz, Neue Stiftingtalstraße 6, Graz, 8010, Austria.
Jan BuceriusDepartment of Radiology, Division of Nuclear Medicine, Medical University of Graz, Auenbruggerplatz 9A, Graz, 8036, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeScintigraphy using

methodsIn this retrospective single-center study, 170 patients with suspected cardiac amyloidosis underwent 99mTc-PYP scintigraphy, including planar imaging and SPECT/CT. Quantitative myocardial uptake was assessed using myocardium-to-vertebra and myocardium-to-rib ratios across predefined left ventricular segments. Imaging findings were correlated with electrocardiographic, echocardiographic, cardiac magnetic resonance (CMR), biomarker, and histopathological data where available.

resultsQuantitative SPECT/CT correlated strongly with Perugini scores and improved diagnostic certainty, particularly in patients with equivocal planar findings. The addition of SPECT/CT led to diagnostic reclassification in more than one-third of patients, with the greatest impact observed in the intermediate Perugini group. Myocardial uptake ratios were significantly associated with NT-proBNP, troponin T, echocardiographic markers of diastolic dysfunction, and CMR parameters including native T1 and extracellular volume. Blood pool activity showed an inverse relationship with myocardial uptake and was associated with both upgrade and downgrade, indicating its role as a confounding factor. Correlation analysis demonstrated only weak associations with renal function and no meaningful correlations with biomarkers or structural parameters. Histopathology (7%) was concordant with imaging findings.

conclusionQuantitative SPECT/CT at 90 min p.i. provides significant incremental diagnostic value, particularly in equivocal cases. Its ability to improve diagnostic classification and distinguish true myocardial uptake from blood pool activity supports its integration into routine diagnostic algorithms for ATTR-CM.

Indexed as

Amyloid Neuropathies, FamilialCardiomyopathiesOrganotechnetium CompoundsSingle Photon Emission Computed Tomography Computed TomographyAgedAged, 80 and overDiphosphonatesFemaleHumansMaleMiddle AgedRetrospective StudiesTime FactorsDiphosphonatesOrganotechnetium Compoundstechnetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid99mTc-pyrophosphateMultimodality imagingPerugini scoreQuantitative imagingSPECT/CTTransthyretin cardiac amyloidosis

Identifiers

PMID42234006
PMCPMC13421186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.